Abbvie Drug Could Be Used to Fight COVID-19

By Stephanie Goldberg and Danny Ecker, Date: October 16, 2020

An AbbVie drug being tested for the treatment of fatty liver disease is one of three drugs selected—out of a pool of 130—for a COVID-19 clinical trial launched by the National Institutes of Health.

Click here to read the story.

This is HUGE news, literally! Get a sneak peek of the new 1.4 million sq. ft. Medline facility going up in Grayslake as part of the larger Cornerstone Development in this new video. Click here ... Read More

Bridge Development Partners has reached a long-term lease agreement with a national logistics company to occupy the entire 189,000 sq. ft. facility recently completed at the Bridge Point North Business Park in Waukegan. The building ... Read More

Abbvie Drug Could Be Used to Fight COVID-19

Previous Post

Next Post

Previous Post

Next Post